These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16620188)

  • 1. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women.
    Pasco JA; Henry MJ; Wilkinson LK; Nicholson GC; Schneider HG; Kotowicz MA
    J Womens Health (Larchmt); 2006 Apr; 15(3):295-300. PubMed ID: 16620188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking, antioxidant vitamins, and the risk of hip fracture.
    Melhus H; Michaëlsson K; Holmberg L; Wolk A; Ljunghall S
    J Bone Miner Res; 1999 Jan; 14(1):129-35. PubMed ID: 9893075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin E on bone turnover markers among US postmenopausal women.
    Hamidi MS; Corey PN; Cheung AM
    J Bone Miner Res; 2012 Jun; 27(6):1368-80. PubMed ID: 22308007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.
    Brownbill RA; Ilich JZ
    J Womens Health (Larchmt); 2006 Apr; 15(3):261-70. PubMed ID: 16620185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.
    Łukaszkiewicz J; Karczmarewicz E; Płudowski P; Jaworski M; Czerwiński E; Lewiński A; Marcinowska-Suchowierska E; Milewicz A; Spaczyński M; Lorenc RS;
    Med Sci Monit; 2008 Dec; 14(12):PH65-70. PubMed ID: 19043376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers reduce bone resorption marker in early postmenopausal women.
    Pasco JA; Henry MJ; Nicholson GC; Schneider HG; Kotowicz MA
    Ann Hum Biol; 2005; 32(6):738-45. PubMed ID: 16418047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis].
    Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J
    Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
    Tengstrand B; Cederholm T; Söderqvist A; Tidermark J
    Clin Nutr; 2007 Aug; 26(4):460-5. PubMed ID: 17498850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women.
    Pongchaiyakul C; Kosulwat V; Charoenkiatkul S; Chailurkit LO; Rojroongwasinkul N; Rajatanavin R
    J Med Assoc Thai; 2008 Mar; 91(3):295-302. PubMed ID: 18575280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
    Bügel S; Sørensen AD; Hels O; Kristensen M; Vermeer C; Jakobsen J; Flynn A; Mølgaard C; Cashman KD
    Br J Nutr; 2007 Feb; 97(2):373-80. PubMed ID: 17298708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ; Im JA; Kim SH
    Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2008 Apr; 24(4):207-13. PubMed ID: 18382907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Zikan V; Stepan JJ
    Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.